Medical Supplies & Devices Analyst Patel holds a post earnings conference call with CFO D’Arecca on May 9 at 11 am hosted by JPMorgan.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HAE:
- Haemonetics: Buy Rating Affirmed Amid Strong Q4 Performance and Margin Improvements
- Haemonetics Approves Strategic Alignment Initiative in May 2025
- Haemonetics sees FY26 adjusted EPS $4.70-$5.00, consensus $4.93
- Haemonetics reports Q4 adjusted EPS $1.24, consensus $1.22
- HAE Earnings this Week: How Will it Perform?